Beth O. Van Emburgh
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, RNA modifications and cancer
Most-Cited Works
- → DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B(2007)377 cited
- → DNA methylation in development and human disease(2008)266 cited
- → Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer(2016)206 cited
- → Acquired resistance to EGFR‐targeted therapies in colorectal cancer(2014)160 cited
- → TGFα and Amphiregulin Paracrine Network Promotes Resistance to EGFR Blockade in Colorectal Cancer Cells(2014)113 cited
- → A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding(2009)98 cited
- → Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants(2011)70 cited
- → Involvement of p53 and p16 Tumor Suppressor Genes in Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma(2004)53 cited
- → Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer(2011)27 cited
- → Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer(2007)22 cited